Rubber band ligation is the most widely used office-based procedure for treating internal hemorrhoids, and it works by cutting off blood supply to the swollen tissue so it shrivels and falls off on its own. The technique has been around since the 1960s and remains a go-to option for hemorrhoids that bleed or prolapse but are not severe enough to need surgery. It is also used in a completely different context to treat dangerous variceal bleeding in the esophagus, making it one of the more versatile tools in gastroenterology.
How the Procedure Works
The concept is straightforward. A small rubber band is placed around the base of an internal hemorrhoid, typically using a suction device or grasping forceps inserted through an anoscope. The band squeezes the tissue tightly enough to block blood flow. Over the following days, the tissue starves, dies, and sloughs off, usually within about a week. What remains is an ulcerated area that heals with scar tissue, and that scar anchors the remaining tissue in place so it no longer prolapses or bleeds.
The strangulating effect of the band leads to necrosis of the hemorrhoidal tissue, and the resulting scarring fixes the underlying tissue layer to the rectal wall, which is the actual therapeutic goal.
Pain during and after the procedure varies. The bands must be placed above the dentate line, a natural boundary in the anal canal where nerve sensation shifts from sharp, skin-like pain to the duller stretch sensation of internal tissue. If a band lands too low, the patient will know immediately. When bands are placed correctly, most people feel pressure or a dull ache that lasts a day or two rather than sharp pain. A comparison of suction-based versus forceps-based banding devices found that the suction method produced significantly less pain both during the procedure and at 24 hours afterward.
Which Hemorrhoids It Treats Best
Internal hemorrhoids are graded on a scale of one to four based on how much they prolapse. Grade I hemorrhoids bulge into the anal canal but do not prolapse. Grade II prolapse during straining but retract on their own. Grade III prolapse and need to be pushed back in manually. Grade IV are permanently prolapsed and cannot be reduced. Rubber band ligation is considered most appropriate for grade I through III hemorrhoids, with the best results seen in earlier grades.
A study comparing outcomes across grades found that efficacy was about 88% for grade II hemorrhoids but dropped to roughly 69% for grade III. Grade III hemorrhoids also required more bands and had a higher recurrence rate: about 33% compared to roughly 15% for grades I and II. Interestingly, for grade III disease, placing four or more bands lowered the recurrence rate compared to fewer bands.
Grade IV hemorrhoids are generally not suitable candidates for banding alone and usually need surgical removal. Some practitioners treat selected grade IV cases with banding, but this is uncommon in clinical guidelines.
Single Session Versus Multiple Sessions
There has been debate about whether to band one hemorrhoid per visit or multiple hemorrhoids in a single sitting. The traditional approach was one band per session, with return visits every few weeks. Banding multiple hemorrhoids at once is faster and cheaper, but it does come with tradeoffs. A study comparing the two approaches found that patients who received multiple bands in one session reported discomfort and pain about 29% of the time, compared to roughly 5% with single banding. They also experienced more minor side effects like urinary hesitancy and vasovagal symptoms. No major complications like severe bleeding or pelvic infection were seen in either group, and the authors concluded that multiple banding in a single session is a safe and cost-effective alternative for most patients.
How It Compares to Surgery
The central tension with rubber band ligation is straightforward: it is easier on the patient but less definitive than surgical hemorrhoidectomy. Multiple systematic reviews have confirmed this pattern. A Cochrane review found that excisional surgery provides better long-term symptom control, especially for grade III hemorrhoids, but at the cost of more pain, more complications, and more time away from work. Despite those downsides, patient satisfaction turned out to be similar between the two approaches, suggesting that many people value a complete cure highly enough to accept a harder recovery.
A meta-analysis of randomized trials echoed this: surgery controlled symptoms better, but banding produced less pain and fewer complications like bleeding, urinary retention, and anal stenosis. Patient satisfaction was again equal across both groups.
The numbers from one large retrospective study illustrate the gap in single-procedure effectiveness clearly. Surgery resolved hemorrhoids in about 96% of cases with a single procedure. A single round of banding was effective in only about 52% of cases, and roughly 35% of banding patients needed a second session.
A cost-effectiveness analysis based on a randomized trial of grade III hemorrhoids put some concrete figures on the tradeoff. Surgery cost roughly €1,364 more in hospital costs and produced a modest improvement in quality-adjusted life years. The probability of surgery being cost-effective depended heavily on how much a health system was willing to pay per unit of benefit: at a threshold of €20,000 per quality-adjusted life year, surgery was cost-effective less than half the time, but at €50,000 it was cost-effective about 84% of the time. For avoiding recurrence specifically, surgery was almost always the better investment.
For many patients with grade II hemorrhoids, though, the calculus favors banding. The recurrence rates are lower at earlier grades, the procedure can be repeated if needed, and the recovery is dramatically easier. Surgery tends to enter the conversation when banding has been tried and failed, or when the disease is advanced enough that the probability of needing repeat procedures makes it less appealing.
How It Compares to Other Office Procedures
Rubber band ligation is not the only non-surgical option. Infrared coagulation and injection sclerotherapy are two alternatives, and each has its own profile. A comparative analysis found that at 12 months, similar proportions of patients were symptom-free regardless of which treatment they received. However, fewer patients who underwent banding needed retreatment for recurrence, giving it better long-term durability. The tradeoff was that banding caused more post-treatment pain than infrared coagulation, which had both fewer and less severe complications.
A meta-analysis pooling data from several trials found no significant difference in overall effectiveness between banding and infrared coagulation. But when it came to recurrence, banding had the edge: the recurrence rate in the banding group was lower. The meta-analysis also suggested that the complication rate for banding was lower than for infrared coagulation after adjusting for study heterogeneity, though this finding was less robust.
Injection sclerotherapy, where a chemical agent is injected into the hemorrhoid to shrink it, tends to be the least durable option. It is gentler still but more likely to need repeating. In practice, many clinicians view the three methods as a spectrum: sclerotherapy for the smallest, least bothersome hemorrhoids; infrared coagulation for patients who prioritize minimal pain; and banding when longer-lasting results matter most.
Complications and Warning Signs
Rubber band ligation is generally safe, but it is not complication-free. The most common issues are mild and expected: pain, a sensation of fullness, minor bleeding when the dead tissue sloughs off, and occasional urinary difficulty. These typically resolve within a few days.
Bleeding is the complication that gets the most attention. Some bleeding when the banded tissue falls off is normal, usually around day five to ten. Significant bleeding is uncommon. One concern has been whether patients taking blood-thinning medications face higher risks. A study of 364 patients on various antithrombotic drugs found that the overall bleeding rate was not statistically different from patients not on these medications. However, patients taking clopidogrel specifically accounted for a disproportionate share of significant bleeding episodes, so extra caution with that particular drug is warranted.
The most feared complication is pelvic or perineal sepsis, a deep infection that can become life-threatening. This is exceedingly rare but has been documented in case reports. One hypothesis for why it occurs involves the tissue death and sloughing after banding, which can create a route for gut bacteria to invade deeper tissues. A case report described a patient who presented with severe anal pain and urinary difficulty after banding and deteriorated rapidly over three days, ultimately dying from fulminant perineal sepsis. Patients should be told to seek immediate medical attention if they develop fever, inability to urinate, or worsening pain in the days after the procedure, because early recognition and aggressive treatment are critical when sepsis does occur.
Long-Term Outcomes and Recurrence
One of the most useful things a patient can know about banding is that it works well but is not always permanent. A study tracking patients over more than a decade found that the probability of the treatment still holding was about 77% at five years and roughly 68% at ten years. In other words, about two-thirds of patients were still cured after a decade, and the rest had experienced some recurrence of symptoms.
When symptoms do come back, rebanding is a reasonable option. A large series found an initial success rate of about 71%. When recurrent symptoms were treated with additional banding sessions, the success rates for first, second, and third recurrences were approximately 74%, 61%, and 65%, respectively. Factoring in repeat treatments, the cumulative success rate climbed to about 80%.
This is actually one of the procedure’s practical strengths. Because it can be repeated easily in an office setting without general anesthesia, patients who recur are not automatically pushed toward surgery. Many people go through two or even three rounds of banding over the years before the question of surgery seriously arises.
Special Populations
A natural concern is whether banding is safe for people whose medical conditions make any procedure riskier. A study specifically looked at three groups that clinicians often worry about: people with compromised immune systems, patients with hemophilia, and pregnant women. The results were reassuring, with only three minor complications across the entire cohort: one minor bleed in a hemophilia patient, one thrombosis in an HIV-positive patient, and one episode of severe rectal pain in a control patient.
As noted earlier, patients on blood thinners deserve individual risk assessment. Aspirin and warfarin users did not show significantly increased bleeding in the available data, but clopidogrel users did have a higher rate of significant bleeding events. Many practitioners will ask patients to discuss temporarily stopping clopidogrel with their prescribing doctor before banding, though this decision has to weigh the cardiac or vascular reason the patient is on the drug in the first place.
Beyond Hemorrhoids: Esophageal Variceal Ligation
The rubber band concept has been adapted for a very different and more dangerous problem: bleeding from esophageal varices. These are swollen veins in the esophagus that develop in people with liver disease, and when they rupture, the bleeding can be fatal. In 1989, the technique of endoscopic variceal ligation was introduced as an adaptation of hemorrhoidal banding. Instead of an anoscope, the bands are deployed through a flexible endoscope, and instead of hemorrhoidal cushions, the targets are variceal columns in the esophageal wall.
The mechanism is the same in principle: the band strangles the tissue, cutting off blood flow and causing it to necrose and slough. Because the varices are in the superficial esophageal mucosa, the reaction is usually limited to the surface layers. Eradication of varices typically requires two to four banding sessions, and complete eradication is achieved in about 90% of patients, although varices can recur.
Bleeding after esophageal banding is a real concern, particularly in the emergency setting. A retrospective analysis found an overall bleeding rate of about 8% after endoscopic band ligation. When the ligation was performed electively as a scheduled procedure, the bleeding rate was much lower, around 4%. Emergency ligation for active hemorrhage carried a higher rate of about 12%. Bleeding from the ligation site specifically was 7% after emergency treatment but only 0.5% after elective treatment. Most bleeding episodes after elective banding occurred within four days, while after emergency banding they could occur up to about 11 days later.
Risk factors for early rebleeding after esophageal variceal ligation have been studied. In one analysis of 342 patients, about 8% developed early rebleeding, with most episodes occurring between days 7 and 13. The strongest predictor was moderate to severe ascites, followed by the number of bands placed, the extent of the varices, and prolonged clotting times. About a quarter of patients who rebled died despite treatment, underscoring how high the stakes are with this application compared to hemorrhoidal banding.
Other Uses of Band Ligation
The technique has found its way into a few other clinical niches. One is the treatment of Dieulafoy’s lesions, which are rare but potentially serious sources of gastrointestinal bleeding caused by an abnormally large artery sitting just beneath the gut lining. A review of published cases found that band ligation achieved initial hemostasis in nearly all patients with bleeding Dieulafoy’s lesions, with rebleeding rates generally at 10% or below, comparable to the alternative approach of using endoscopic clips.
This versatility is part of what has kept rubber band ligation relevant for decades. The underlying principle of mechanically strangling unwanted or dangerous tissue with a small elastic band is simple enough that it translates across anatomical sites, yet effective enough to remain competitive with newer technologies. In hemorrhoid treatment, where it is most commonly used, it occupies a practical middle ground between conservative management and surgery: more effective than creams and dietary changes, less invasive than an operating room procedure, and repeatable when the first round does not stick.